Clinical trial · Observational
A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
A Prospective Study to Better Understand the Molecular, Immune and Metabolic Mechanisms Involved in Glioblastoma Recurrence and Progression, in the Aim to Identify New Therapeutic Targets and to Improve Current Therapies
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
BORDEAUX-GLIO is a prospective, monocentric study which will describe the molecular, immune and metabolic pathways involved in the progression and relapse of glioblastoma, using blood and tumor samples from patients who have undergone surgery for newly diagnosed or recurrent glioblastoma in the center.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Glioblastoma | Glioblastoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| samples | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Recruited patient
- description
- Glioblastoma patient with indication for neurosurgery
- interventionNames
- Other: samples
Primary outcomes (3)
- measure
- Molecular mechanism
- timeFrame
- at inclusion (T0)
- description
- Description of the molecular mechanism involved in the progression and recurrence of glioblastoma
- measure
- Metabolic mechanism
- timeFrame
- at inclusion (T0)
- description
- Description of the metabolic mechanism involved in the progression and recurrence of glioblastoma.
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients of 18 years or older, with highly suspected glioblastoma on neuro-imagery * Planned surgical tumor resection, * No objection to participate in research * Signed genetic consent Exclusion Criteria: * Patients under guardianship, curatorship or protective supervision * Taking immunosuppressants * Pregnant or breast-feeding women * Patients deprived of their liberty by judicial or administrative decision, or under psychiatric care
References
Publications (0)
Data not yet available